GeneSight Mental Health Monitor shows misunderstanding of depression and treatment

New poll shows 83% of people with depression agree life would be easier if others could understand their depression

2021-04-28

(Press-News.org) In a new nationwide poll, the GeneSight® Mental Health Monitor found that 83% of people with depression agree that life would be easier if others could understand their depression. Yet, most people who have not experienced depression may not be able to understand the challenges, including its treatment.

"Depression is one of the most misunderstood disorders. When people misinterpret patients with depression as 'lazy' or 'dramatic,' they are vastly underestimating and misunderstanding the debilitating symptoms of major depressive disorder," said Mark Pollack, M.D., chief medical officer for the GeneSight test at Myriad Genetics. "That is why we are working with the Depression and Bipolar Support Alliance, so that loved ones can offer more empathetic support and people with depression won't feel so alone."

For Mental Health Awareness Month (May), GeneSight and the Depression and Bipolar Support Alliance (DBSA) have partnered to raise awareness and understanding for how a person who has major depressive disorder feels, and why it can be so hard to seek treatment.

Lack of Understanding and Empathy about Depression

Three out of four people living with depression said they desire support from their loved ones including just listening or saying supportive things like: "How can I help?" or "Do you want to talk about it?". Instead, nearly half of those with depression said they were more likely to hear statements like: "You need to get over it/snap out of it" or "We all get sad sometimes".

"Depression is a serious but treatable medical condition that affects how a person feels, thinks, and acts. Though, typically characterized by feelings of sadness, depression symptoms may appear as irritability or apathy," said Michael Thase, M.D., professor of psychiatry, Perelman School of Medicine and the Corporal Michael J. Crescenz VA Medical Center, and DBSA scientific advisory board member. "We must work together - providers, patients, family and friends - to continue to reduce the impact of stigma. Misunderstanding the disorder may lead to people feeling embarrassed and/or unwilling to seek the treatment they need."

Nearly half of those either diagnosed with depression or concerned they may have depression say they feel ashamed/embarrassed when others found out they were suffering from depression, according to the GeneSight Mental Health Monitor.

Pandemic Prompts Search for New Treatment

More than half of those diagnosed with depression indicated in the poll that they started a new treatment since the start of the pandemic. Nevertheless, for some, starting a new depression medication doesn't guarantee success.

More than half of people diagnosed with depression said they have tried four or more depression medications in their lifetime, with nearly 1 in 4 respondents reporting they have tried six or more medications to try to find relief.

"I couldn't get out of bed to take care of my children, much less go to the doctor multiple times to try new medicines that 'might' help," said Amanda, a 25-year-old woman who was diagnosed with major depressive disorder. "The years of trial and error were so frustrating and discouraging. You feel like you are stuck living that way."

Those who indicated in the GeneSight Mental Health Monitor that they had experienced the trial-and-error process described the experience as: "On a rollercoaster" (51%) "I'm just waiting for the next side effect" (45%) "Walking through a maze blindfolded" (44%) "Playing a game of darts, only I'm the dartboard" (42%)

While 4 in 10 of those diagnosed with depression say they are not confident that their depression medications will work for them, 7 in 10 would feel "hopeful" if their doctor recommended genetic testing as part of their treatment plan.

Genetic testing, like the GeneSight Psychotropic test, analyzes how a patient's genes may affect their outcomes with medications commonly prescribed to treat depression, anxiety and other psychiatric conditions.

"With just a simple cheek swab, the GeneSight test provides your clinician with information about which medications may require dose adjustments, be less likely to work, or have an increased risk of side effects based on a patient's genetic makeup," said Dr. Pollack. "It's one of many tools in a physician's toolbox that may help get patients on the road to feeling more like themselves again."

Conquering the Depression Disconnect

While 7 in 10 adults said that they are more conscious about their own or others' mental health challenges than they were before the pandemic began, less than half of adults are very confident they can recognize if a loved one is suffering from depression, according to the GeneSight Mental Health Monitor.

For a better understanding of depression and treatment, visit KnowMentalHealth.com. For more information on how genetic testing can help inform clinicians in depression treatment, please visit genesight.com.

INFORMATION:

The GeneSight® Mental Health Monitor The GeneSight Mental Health Monitor is a nationwide survey of U.S. adults conducted by ACUPOLL Precision Research, Inc. in March 2021. The survey was conducted among a statistically representative sample of U.S. adults age 18+, including a U.S. representative sample of adults who have been diagnosed with depression. The margin of error in survey results for the total base population at a 95% confidence interval is +/- 3%.

Myriad Genetics Myriad Genetics, Inc. is a leading genetic testing and precision medicine company dedicated to advancing health and wellbeing, empowering individuals with vital genetic insights and enabling healthcare providers to better detect, treat and prevent disease. Myriad discovers and commercializes genetic tests that determine the risk of developing disease, accurately diagnose disease, assess the risk of disease progression, and guide treatment decisions across medical specialties where genetic testing can significantly improve patient care and lower healthcare costs. For more information on how Myriad fulfills its purpose, please visit the company's website: http://www.myriad.com. Myriad, the Myriad logo, BART, BRACAnalysis, Colaris, Colaris AP, myPath, myRisk, Myriad myRisk, myRisk Hereditary Cancer, myChoice, myPlan, BRACAnalysis CDx, Tumor BRACAnalysis DCx, myChoice CDx, Vectra, Prequel, Foresight, GeneSight, riskScore and Prolaris are trademarks or registered trademarks of Myriad Genetics, Inc. or its wholly owned subsidiaries in the United States and foreign countries. MYGN-F, MYGN-G.

The GeneSight® Test The GeneSight Psychotropic test from Myriad Genetics is the category-leading pharmacogenomic test for certain medications commonly prescribed for depression, anxiety and other psychiatric conditions. The GeneSight test can help inform doctors about how a patient's genes that may impact how they metabolize or respond to certain psychiatric medications. It has been given to more than one million patients by tens of thousands of clinicians to provide genetic information that is unique to each patient. The GeneSight test supplements other information considered by a doctor as part of a comprehensive medical assessment. Learn more at GeneSight.com.

Depression and Bipolar Support Alliance The Depression and Bipolar Support Alliance (DBSA) is a not-for-profit, 501(c)(3) organization that provides hope, help, support and education to serve the estimated 21 million people throughout the U.S. who live with mood disorders. Programs and resources are offered through our website, dbsalliance.org, and through our 500+ support groups and 150+ chapters across the country. DBSA emphasizes the value of peer support as a crucial resource for wellness. The term peer describes someone who lives with a mood disorder. DBSA believes in the strength and resilience of each person and supports the individual's right to create his/her/their own path to wellness. DBSA also serves caregivers, families and friends of people living with mood disorders because family and social support are central to wellness.

ELSE PRESS RELEASES FROM THIS DATE:

Parents more lenient about alcohol with teens who experience puberty early

2021-04-28

UNIVERSITY PARK, Pa. -- Parents of teens who went through puberty early may be more lenient when it comes to letting them consume alcohol, according to a new Penn State study. But the researchers said that even if adolescents appear more mature, drinking alcohol is still not safe for them. Rebecca Bucci, a PhD candidate in criminology at Penn State, said the study -- published today (April 28) in Child Development -- aimed to discover why adolescents who go through puberty early are more likely than their peers to drink alcohol. "A surprising proportion of parents in our study allowed their early-developing children to drink alcohol at the age of 14 -- in fact, ...

Can genetics predict bothersome hot flashes?

2021-04-28

CLEVELAND, Ohio (April 28, 2021)--Hot flashes are a hallmark of the menopause transition. Yet, they don't strike with the same frequency or severity for all women. A new study suggests that some of the same genetic factors that affect a woman's reproductive life cycle may also help predict her likelihood of having bothersome hot flashes. Study results are published online today in Menopause, the journal of The North American Menopause Society (NAMS). Despite multiple studies on the subject, questions still remain as to why some women are more affected than others by hot flashes and night sweats during the menopause transition. Genetics may be one reason, ...

Espresso, latte or decaf? Genetic code drives your desire for coffee

2021-04-28

Whether you hanker for a hard hit of caffeine or favour the frothiness of a milky cappuccino, your regular coffee order could be telling you more about your cardio health than you think. In a world first study of 390,435 people, University of South Australia researchers found causal genetic evidence that cardio health - as reflected in blood pressure and heart rate - influences coffee consumption. Conducted in partnership with the SAHMRI, the team found that people with high blood pressure, angina, and arrythmia were more likely to drink less coffee, decaffeinated coffee or avoid coffee altogether compared to those without such symptoms, and that this was based on genetics. Lead researcher ...

Treating neurological symptoms of CHARGE syndrome

2021-04-28

CHARGE syndrome is a rare genetic disorder affecting about 1 in 10,000 newborns. It can lead to neurological and behavioural disorders for which no treatment is currently available. Dr. Kessen Patten and his team, from the Institut national de la recherche scientifique (INRS) have just discovered a compound that could alleviate these symptoms. The results of their research were published in the journal EMBO Reports. Understanding Neurological Disorders First described in 1979, CHARGE syndrome is caused by mutations in the CHD7 gene and is associated with neurodevelopmental disorders such as intellectual disability, attention deficit disorder with or without hyperactivity, seizures and autism spectrum disorder. Dr. Patten's research team studied the ...

Researchers find how tiny plastics slip through the environment

2021-04-28

Washington State University researchers have shown the fundamental mechanisms that allow tiny pieces of plastic bags and foam packaging at the nanoscale to move through the environment. The researchers found that a silica surface such as sand has little effect on slowing down the movement of the plastics, but that natural organic matter resulting from decomposition of plant and animal remains can either temporarily or permanently trap the nanoscale plastic particles, depending on the type of plastics. The work, published in the journal Water Research, could help researchers develop better ways to filter out and clean up pervasive plastics from the environment. The researchers include Indranil Chowdhury, assistant professor in WSU's Department of Civil and Environmental ...

The growing promise of community-based monitoring and citizen science

2021-04-28

Over recent decades, community-based environmental monitoring (often called "citizen science") has exploded in popularity, aided both by smartphones and rapid gains in computing power that make the analysis of large data sets far easier. Publishing in BioScience, handling editors Rick Bonney, of Cornell University, Finn Danielsen, of the Nordic Foundation for Development and Ecology, and colleagues share a special section that highlights numerous community-based monitoring programs currently underway. They also describe the potential for such efforts to advance the scientific enterprise well into the future and make recommendations for best practices and future directions. In an article ...

Young people who experience bullying are more likely to fantasize about committing acts of violence - study

2021-04-28

Experiencing bullying and forms of aggression in late adolescence and early adulthood is linked to a marked increase in the likelihood of having daydreams or fantasies about hurting or killing people, according to a new study. While research has shown that significant numbers of people fantasise about inflicting harm*, little is known about the processes behind such "violent ideations". A team led by a University of Cambridge professor tracked the self-reported thoughts and experiences of 1,465 young people from schools across the Swiss city of Zurich at the ages of 15, 17 and 20. Researchers gathered data on whether violent thoughts had occurred in the last 30 days, and the types of bullying or aggression experienced over the last 12 months. They used questionnaires ...

Drones provide bird's eye view of how turbulent tidal flows affect seabird foraging habits

2021-04-28

The foraging behaviour of seabirds is dramatically affected by turbulence caused by natural coastal features and manmade ocean structures, new research has shown. In a first-of-its-kind study, scientists from the UK and Germany used drones to provide a synchronised bird's eye view of what seabirds see and how their behaviour changes depending on the movement of tidal flows beneath them. The research focused on the wake of a tidal turbine structure set in a tidal channel - Strangford Lough in Northern Ireland - that has previously been identified as a foraging hotspot for terns. Through a combination of drone tracking and advanced statistical modelling, it showed that terns were more likely to actively forage over ...

Only one in four people experience mild systemic side effects from COVID-19 vaccines

2021-04-28

One in four people experience mild, short lived systemic side effects after receiving either the Pfizer or AstraZeneca vaccine, with headache, fatigue and tenderness the most common symptoms. Most side effects peaked within the first 24 hours following vaccination and usually lasted 1-2 days. The study published today in the Lancet Infectious Diseases is the first large scale study to compare the two vaccines and investigate the prevalence of mild side effects of the UK's vaccination programme. The analysis by researchers from King's College London of data from ...

Nearly 25% of children and adolescents invountarily admitted to psychiatric hospitals

2021-04-28

For the first time, researchers have systematically analysed social and clinical factors associated with psychiatric hospital admission of children and adolescents, finding nearly one-quarter (23.6%) were admitted involuntarily. The study was published in The Lancet Child & Adolescent Health journal. Researchers also found that children and adolescents who were involuntarily hospitalised were nearly three times more likely to belong to a Black rather than a white ethnic group than those hospitalised voluntarily and more likely to have a diagnosis of psychosis, substance misuse, or intellectual disability. Involuntary hospitalisation is a legal procedure used to compel an individual to ...

GeneSight Mental Health Monitor shows misunderstanding of depression and treatment

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: